JP2011502998A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011502998A5 JP2011502998A5 JP2010532306A JP2010532306A JP2011502998A5 JP 2011502998 A5 JP2011502998 A5 JP 2011502998A5 JP 2010532306 A JP2010532306 A JP 2010532306A JP 2010532306 A JP2010532306 A JP 2010532306A JP 2011502998 A5 JP2011502998 A5 JP 2011502998A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- bicyclo
- compound
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98460107P | 2007-11-01 | 2007-11-01 | |
| US4966508P | 2008-05-01 | 2008-05-01 | |
| PCT/US2008/082140 WO2009059243A1 (en) | 2007-11-01 | 2008-10-31 | Treating and preventing viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011502998A JP2011502998A (ja) | 2011-01-27 |
| JP2011502998A5 true JP2011502998A5 (https=) | 2011-12-15 |
Family
ID=40591505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532306A Pending JP2011502998A (ja) | 2007-11-01 | 2008-10-31 | ウイルス感染の治療および予防 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8466177B2 (https=) |
| EP (1) | EP2217573A4 (https=) |
| JP (1) | JP2011502998A (https=) |
| CN (1) | CN101990534A (https=) |
| WO (1) | WO2009059243A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20121524A1 (es) | 2010-01-27 | 2012-12-03 | Viiv Healthcare Co | Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos |
| US8933075B2 (en) * | 2010-06-17 | 2015-01-13 | Fuzians Biomedicals, Inc. | Compounds useful as antiviral agents, compositions, and methods of use |
| KR101159000B1 (ko) * | 2010-06-18 | 2012-06-21 | (주) 에빅스젠 | 신규한 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 ａｉｄｓ 예방 또는 치료용 약학 조성물 |
| US20140303074A1 (en) * | 2011-12-16 | 2014-10-09 | The J. David Gladstone Institutes | Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription |
| KR101893988B1 (ko) * | 2018-05-16 | 2018-08-31 | (주)에빅스젠 | 로다닌 유도체를 함유하는 aids 예방 또는 치료용 약학 조성물 |
| CN108658891B (zh) * | 2018-07-03 | 2020-09-29 | 河南农业大学 | 2-硫代噻唑烷-4-酮、衍生物及其制备方法 |
| CN111995622B (zh) * | 2020-08-20 | 2022-04-15 | 复旦大学 | 化合物及其用途 |
| WO2025252235A1 (zh) * | 2024-06-07 | 2025-12-11 | 宜坤行健生物医药（上海）有限公司 | 一种用于调节β2整联蛋白的化合物及其药物组合物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3345334A (en) | 1967-03-06 | 1967-10-03 | Du Pont | Polyureas, poly (diazolidiones), and process for converting polyureas to poly |
| GB1601310A (en) | 1978-05-23 | 1981-10-28 | Lilly Industries Ltd | Aryl hydantoins |
| EP0915090A1 (en) | 1992-09-10 | 1999-05-12 | Eli Lilly And Company | Compounds useful as hypoglycemic agents and for treating Alzheimer's disease |
| DE4331162A1 (de) | 1993-09-14 | 1995-03-16 | Bayer Ag | Verfahren zur Herstellung von Cyaninfarbstoffen |
| US5684024A (en) * | 1996-01-25 | 1997-11-04 | Viropharma Incorporated | Pyrazole dimers compositions and methods for treating influenza |
| ID27787A (id) | 1998-08-21 | 2001-04-26 | Viro Pharma Inc | Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan |
| US20020064736A1 (en) | 2000-09-27 | 2002-05-30 | Fuji Photo Film Co., Ltd. | Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye |
| JP2006500399A (ja) | 2002-04-30 | 2006-01-05 | メルク エンド カムパニー インコーポレーテッド | ナトリウムチャンネルブロッカーとしての、アリール−結合−アリール置換された、チアゾリジン−ジオンおよびオキサゾリジン−ジオン |
| AU2003291024A1 (en) | 2002-11-13 | 2004-06-03 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives and pharmaceutical compositions containing them |
| DE10348023A1 (de) * | 2003-10-15 | 2005-05-19 | Imtm Gmbh | Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| WO2005041951A2 (en) | 2003-10-28 | 2005-05-12 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives for use as antiviral agents |
| EP1896033A4 (en) * | 2005-06-15 | 2010-12-22 | New York Blood Ct Inc | ANTIVIRAL COMPOSITIONS WITH HETEROCYCLIC SUBSTITUTED PHENYLFURANES AND RELATED COMPOUNDS |
| GB0521373D0 (en) | 2005-10-20 | 2005-11-30 | Kudos Pharm Ltd | Pthalazinone derivatives |
-
2008
- 2008-10-31 WO PCT/US2008/082140 patent/WO2009059243A1/en not_active Ceased
- 2008-10-31 CN CN2008801139457A patent/CN101990534A/zh active Pending
- 2008-10-31 US US12/682,341 patent/US8466177B2/en not_active Expired - Fee Related
- 2008-10-31 JP JP2010532306A patent/JP2011502998A/ja active Pending
- 2008-10-31 EP EP08844884A patent/EP2217573A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011502998A5 (https=) | ||
| JP7119158B2 (ja) | タンパク質調節因子として有用な複素環式アミド | |
| AU2023270335B2 (en) | N4-hydroxycytidine and derivatives and anti-viral uses related thereto | |
| US12414961B2 (en) | Substituted nucleosides and nucleotides for treating viral infections | |
| CA3082191C (en) | N4-hydroxycytidine and derivatives and anti-viral uses related thereto | |
| AU2018344902B2 (en) | Modulators of stimulator of interferon genes (STING) useful in treating HIV | |
| CA2972014A1 (en) | Fused pyrimidine compounds for the treatment of hiv | |
| JP2017525753A5 (https=) | ||
| WO2017133667A1 (en) | Pyrimidine and pyridine derivatives and use in treatment, amelioration or prevention of influenza thereof | |
| EP4196228A1 (en) | N-cyclyl-sulfonamides useful for inhibiting raf | |
| TW201408683A (zh) | 一種替諾福韋前藥及其在醫藥上的應用 | |
| JP2016537346A5 (https=) | ||
| US12440494B2 (en) | Compounds useful for inhibiting RAF dimers | |
| WO2013173254A1 (en) | Bicyclic compounds as kinases inhibitors | |
| WO2017106710A1 (en) | Nucleotide and nucleoside therapeutic compositions and uses related thereto | |
| JP2014510147A5 (https=) | ||
| US11192914B2 (en) | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto | |
| US20190085013A1 (en) | Nucleotide and nucleoside therapeutic compositions and uses related thereto | |
| EP2217573A1 (en) | Treating and preventing viral infections | |
| Rawal et al. | 2′-Fluoro-6′-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: In vitro anti-HBV activity against the lamivudine–entecavir resistant triple mutant and its mechanism of action | |
| JP2017535549A5 (https=) | ||
| CA2857441A1 (en) | Carboxamide-substituted heteroaryl-pyrazoles and their use | |
| US10669270B2 (en) | Amide-sulfamide derivatives, compositions, and uses related to CXCR4 inhibition | |
| EP4651872A1 (en) | Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis | |
| AU2024267852A1 (en) | 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto |